# Ascentage Pharma Group International: financial statements, quarterly

AAPG · Nasdaq · CIK 2023311 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aapg.md) · [Financials](/companies/aapg/financials.md) · [Filings](/companies/aapg/filings.md) · [Insiders](/companies/aapg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aapg/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: |
| Cash and equivalents | $m | [142](/filings/0001213900-25-032599.md) | [122](/filings/0001213900-25-032599.md) |
| Current assets | $m | not reported | [202](/filings/0001213900-25-032599.md) |
| Current liabilities | $m | not reported | [160](/filings/0001213900-25-032599.md) |
| Total liabilities | $m | not reported | [321](/filings/0001213900-25-032599.md) |
| Shareholders' equity | $m | not reported | [36.2](/filings/0001213900-25-032599.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 373,322,192 at 2026-04-01, from the cover of the [20-F filed 2026-04-29](/filings/0001213900-26-049412.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.